Should You Buy C4 Therapeutics Inc (CCCC) Stock After it Is Up 51.72% in a Week?

C4 Therapeutics Inc (CCCC) stock has risen 51.72% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

C4 Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CCCC!

See Full CCCC Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With CCCC Stock Today?

C4 Therapeutics Inc (CCCC) stock is up 12.8% while the S&P 500 is lower by -0.09% as of 11:13 AM on Wednesday, Feb 28. CCCC is higher by $1.25 from the previous closing price of $9.75 on volume of 1,867,712 shares. Over the past year the S&P 500 has risen 27.41% while CCCC is higher by 105.99%. CCCC lost -$2.67 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for C4 Therapeutics Inc click here.

More About C4 Therapeutics Inc

C4 Therapeutics Inc is a bio-pharmaceutical company. The company is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to eliminate disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases. Click Here to get the full Stock Report for C4 Therapeutics Inc stock.